Overview

Tissue Repair Gel in Venous Leg Ulcers (US)

Status:
RECRUITING

Trial end date:
2027-02-01

Target enrollment:

Participant gender:

Summary

The goal of this clinical trial is to learn if TR987 0.1% gel + Standard of Care works better than Standard of Care alone to treat Venous Leg Ulcers (VLUs). It will also provide additional information about the safety of drug TR987 0.1% gel.

Phase:

PHASE3

Details

Lead Sponsor:

TR Therapeutics

Treatments:

Gels
Standard of Care